×
Entrez Id:
3565
Gene Symbol:
IL4
IL4
0.010
AlteredExpression
disease
BEFREE
Cytoprotection achieved with IL-4 and IL-13 is mediated by the early activation of signal transducer and activator of transcription 6 (STAT6) in beta cells, leading to the upregulation of anti-apoptotic proteins, including myeloid leukaemia -1 (MCL-1) and B cell lymphoma-extra large (BCLXL).
30338340
2019
×
Entrez Id:
6778
Gene Symbol:
STAT6
STAT6
0.010
AlteredExpression
disease
BEFREE
Cytoprotection achieved with IL-4 and IL-13 is mediated by the early activation of signal transducer and activator of transcription 6 (STAT6 ) in beta cells, leading to the upregulation of anti-apoptotic proteins, including myeloid leukaemia -1 (MCL-1 ) and B cell lymphoma-extra large (BCLXL).
30338340
2019
×
Entrez Id:
406935
Gene Symbol:
MIR143
MIR143
0.010
Biomarker
disease
BEFREE
MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1.
29917183
2018
×
Entrez Id:
5595
Gene Symbol:
MAPK3
MAPK3
0.010
Biomarker
disease
BEFREE
MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1 .
29917183
2018
×
Entrez Id:
23326
Gene Symbol:
USP22
USP22
0.010
Biomarker
disease
BEFREE
USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.
29844011
2018
×
Entrez Id:
406991
Gene Symbol:
MIR21
MIR21
0.020
Biomarker
disease
BEFREE
It was found that MiR-21 was found to be normally upregulated in all types of ML , however, we summarize the important research findings surrounding the role of miR-21 in different types of ML .
29795410
2018
×
Entrez Id:
652995
Gene Symbol:
UCA1
UCA1
0.010
AlteredExpression
disease
BEFREE
We found that lncRNA UCA1 was upregulated in ML cell lines.
29762824
2018
×
Entrez Id:
28951
Gene Symbol:
TRIB2
TRIB2
0.020
Biomarker
disease
BEFREE
A Trib2 -p38 axis controls myeloid leukaemia cell cycle and stress response signalling.
29670085
2018
×
Entrez Id:
5594
Gene Symbol:
MAPK1
MAPK1
0.020
AlteredExpression
disease
BEFREE
Our data provide evidence for a tumour suppressor role of Trib2 in myeloid leukaemia via activation of p38 stress signalling.
29670085
2018
×
Entrez Id:
10598
Gene Symbol:
AHSA1
AHSA1
0.010
AlteredExpression
disease
BEFREE
Our data provide evidence for a tumour suppressor role of Trib2 in myeloid leukaemia via activation of p38 stress signalling.
29670085
2018
×
Entrez Id:
1398
Gene Symbol:
CRK
CRK
0.010
AlteredExpression
disease
BEFREE
Our data provide evidence for a tumour suppressor role of Trib2 in myeloid leukaemia via activation of p38 stress signalling.
29670085
2018
×
Entrez Id:
9402
Gene Symbol:
GRAP2
GRAP2
0.010
AlteredExpression
disease
BEFREE
Our data provide evidence for a tumour suppressor role of Trib2 in myeloid leukaemia via activation of p38 stress signalling.
29670085
2018
×
Entrez Id:
26073
Gene Symbol:
POLDIP2
POLDIP2
0.010
AlteredExpression
disease
BEFREE
Our data provide evidence for a tumour suppressor role of Trib2 in myeloid leukaemia via activation of p38 stress signalling.
29670085
2018
×
Entrez Id:
7965
Gene Symbol:
AIMP2
AIMP2
0.010
AlteredExpression
disease
BEFREE
Our data provide evidence for a tumour suppressor role of Trib2 in myeloid leukaemia via activation of p38 stress signalling.
29670085
2018
×
Entrez Id:
1432
Gene Symbol:
MAPK14
MAPK14
0.010
AlteredExpression
disease
BEFREE
Our data provide evidence for a tumour suppressor role of Trib2 in myeloid leukaemia via activation of p38 stress signalling.
29670085
2018
×
Entrez Id:
25897
Gene Symbol:
RNF19A
RNF19A
0.010
AlteredExpression
disease
BEFREE
Our data provide evidence for a tumour suppressor role of Trib2 in myeloid leukaemia via activation of p38 stress signalling.
29670085
2018
×
Entrez Id:
9232
Gene Symbol:
PTTG1
PTTG1
0.020
Biomarker
disease
BEFREE
Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1 ) Oncoprotein.
29649138
2018
×
Entrez Id:
1977
Gene Symbol:
EIF4E
EIF4E
0.010
Biomarker
disease
BEFREE
The role of eIF4E in myeloid leukemia has been ascertained and drugs targeting its functions have found their place in clinical trials.
29527921
2018
×
Entrez Id:
643911
Gene Symbol:
CRNDE
CRNDE
0.010
AlteredExpression
disease
BEFREE
Results of clinical data showed that the expression of lncRNA-CRNDE was associated with the classification and total survival of myeloid leukemia in clinical patients.
29461608
2018
×
Entrez Id:
861
Gene Symbol:
RUNX1
RUNX1
0.100
GeneticVariation
disease
BEFREE
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.
29438697
2018
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.010
Biomarker
disease
BEFREE
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.
29438697
2018
×
Entrez Id:
11009
Gene Symbol:
IL24
IL24
0.030
Biomarker
disease
BEFREE
In this study, we investigated the role of IL-24 in immunogenicity modulation of the myelogenous leukemia cells.
29420334
2018
×
Entrez Id:
8091
Gene Symbol:
HMGA2
HMGA2
0.010
Biomarker
disease
BEFREE
Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia .
29384529
2018
×
Entrez Id:
27352
Gene Symbol:
SGSM3
SGSM3
0.010
AlteredExpression
disease
BEFREE
Importantly, by querying the connectivity MAP using up- and downregulated genes that are present exclusively in NIK-stabilized LSCs, we discovered that verteporfin has anti-AML effects, suggesting that repurposing verteporfin to target myeloid leukemia is worth testing clinically.
29320732
2018
×
Entrez Id:
4602
Gene Symbol:
MYB
MYB
0.020
Biomarker
disease
BEFREE
MYB -driven transcriptional coactivation with CREB-binding protein (CBP)/P300 is required for acute lymphoblastic and myeloid leukemias , including refractory MLL-rearranged leukemias.
29317678
2018